In the News

Canadian Post-doctoral Fellowships Awarded in type 1 diabetes Research
By JDRF Canada
October 20, 2014

Lilly Canada provided JDRF with $220,000 in 2013-2014 in support of the creation of a national clinical training program to enable young investigators to further engage in medical research associated with type 1 diabetes.

Read More
Tags: Canadian Post-doctoral Fellowships, Research, Lilly Canada, JDRF, T1D
Giant leap against diabetes
By Harvard Gazette
October 14, 2014

Ability to produce embryonic stem cells will allow researchers to push faster toward cure

Read More
Diabetes researchers find faster way to create insulin-producing cells
By University of British Columbia
September 12, 2014

University of British Columbia, in collaboration with BetaLogics Venture, a division of Janssen Research & Development, LLC, has published a study highlighting a protocol to convert stem cells into insulin-producing cells. The new procedure could be an important step in the fight against Type 1 diabetes.

Read More
Fighting diabetes one kick at a time
By JDRF Canada
August 29, 2014

Sun Life Financial and the Canadian Football League (CFL) partner to raise up to $100,000 for JDRF

Read More
Tags: Sun Life, JDRF, type 1 diabetes, CFL, Kick Diabetes Program, Prevention, T1D, Corporate Partnerships, football
JDRF Partner ViaCyte to Immediately Initiate Type 1 Diabetes Clinical Trial
August 21, 2014

JDRF’s partner ViaCyte recently announced the U.S. Food and Drug Administration (FDA) is allowing them to move forward with a clinical trial of its innovative type 1 diabetes (T1D) encapsulated cell replacement therapy called VC-01™ product candidate.

Read More
Tags: ViaCyte, Type 1 Diabetes Clinical Trials, clinical trial, VC-01, encapsulated cell replacement therapy